Together for a Cure: Fundraising Event Aims to Unite the Community for Breast Cancer Research and Support

Susan G. Komen^®, the world’s leading breast cancer organization, today announced it will host the Race for the Cure this fall. The 2024 Komen Chicago Race for the Cure will take place on Saturday, September 28, bringing together survivors, supporters, and advocates to raise critical funds to advance Komen’s mission and provide support for people facing this disease now.

Every 12 minutes, a woman in the U.S. dies from breast cancer. In 2024 alone, an estimated 11,870 women in Illinois will be diagnosed with breast cancer and 1,680 will lose their lives to the disease. Experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. Funds raised at the Race will allow Komen to meet the immediate needs of breast cancer patients through its free Breast Care Helpline and offer services such as patient navigation, financial assistance, and emotional support. It will also fund research breakthroughs that allow more lives to be saved from breast cancer and bring us closer to the cures for all breast cancers.

In 2024, the Komen Financial Assistance program provided financial assistance totaling over $360,000 to over 1,200 people in Illinois who are in breast cancer treatment or living with metastatic breast cancer. Additionally, Komen’s Patient Care Center provided over 1,250 services to over 1,000 people living in Illinois, working to address over 1,400 barriers to care that may otherwise prevent someone from getting the breast health care or support they need.

"We are thrilled to welcome the community to the Susan G. Komen Chicago Race for the Cure this year, where together we can make a profound impact in the fight against breast cancer," said Jaclyn Groves, executive director. "Supporting individuals in our community who are facing breast cancer is essential to our mission, but we cannot do it alone. This year’s Race is not just an event; it is a pivotal moment to secure vital funds that will make equitable care available to all. We hope you can join us as we take a powerful stand against this devastating disease."

What: 2024 Susan G. Komen Chicago Race for the Cure

When: Saturday, September 28, 2024

Where: Soldier Field South Lot – 1410 S. Special Olympics Dr. Chicago, IL 60605

Registration: www.komen.org/chicagorace

This year’s Susan G. Komen Chicago Race for the Cure is made possible by the following sponsors: Marmon Holdings, Inc., Lofthouse, Ford, Cumulus Media, City of Hope Cancer Center, First Watch, Extenet, Gimme Beauty, Old National Bank, Rivers Casino, Claire’s and Pink Wave Water.

Bank of America is the national presenting sponsor and Walgreens, Novartis and Lily are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events.

Join us at the 2024 Susan G. Komen Chicago Race for the Cure this fall to stand with the community in the fight against breast cancer. Your participation will help raise vital funds, provide crucial support services, and advance important research. Together, we can work towards a future without breast cancer.

About Susan G. Komen®

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828523771/en/